Sumitomo Mitsui Trust Group
TMO icon

Sumitomo Mitsui Trust Group’s Thermo Fisher Scientific TMO Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$530M Sell
1,078,539
-16,194
-1% -$8.79M 0.34% 53
2025
Q4 		$634M Sell
1,094,733
-35,021
-3% -$19.8M 0.37% 44
2025
Q3 		$548M Buy
1,129,754
+5,892
+0.5% +$2.74M 0.32% 56
2025
Q2 		$456M Buy
1,123,862
+5,483
+0.5% +$2.29M 0.28% 71
2025
Q1 		$557M Sell
1,118,379
-638
-0.1% -$346K 0.39% 40
2024
Q4 		$582M Buy
1,119,017
+14,576
+1% +$8.01M 0.39% 41
2024
Q3 		$683M Buy
1,104,441
+18,160
+2% +$10.7M 0.47% 31
2024
Q2 		$601M Sell
1,086,281
-73,418
-6% -$42.1M 0.44% 39
2024
Q1 		$674M Sell
1,159,699
-8,484
-0.7% -$4.76M 0.46% 35
2023
Q4 		$620M Sell
1,168,183
-9,061
-0.8% -$4.39M 0.46% 38
2023
Q3 		$596M Sell
1,177,244
-24,517
-2% -$13.1M 0.49% 31
2023
Q2 		$627M Sell
1,201,761
-217,664
-15% -$117M 0.49% 33
2023
Q1 		$818M Buy
1,419,425
+33,124
+2% +$18.7M 0.61% 24
2022
Q4 		$763M Sell
1,386,301
-8,615
-0.6% -$4.56M 0.6% 26
2022
Q3 		$707M Sell
1,394,916
-1,034
-0.1% -$579K 0.58% 25
2022
Q2 		$758M Buy
1,395,950
+48,974
+4% +$27M 0.58% 25
2022
Q1 		$796M Sell
1,346,976
-1,950
-0.1% -$1.12M 0.53% 27
2021
Q4 		$900M Sell
1,348,926
-51,752
-4% -$32.3M 0.55% 26
2021
Q3 		$800M Sell
1,400,678
-81,874
-6% -$44.9M 0.5% 33
2021
Q2 		$748M Sell
1,482,552
-179,151
-11% -$84.5M 0.44% 42
2021
Q1 		$758M Buy
1,661,703
+28,876
+2% +$13.8M 0.47% 36
2020
Q4 		$761M Sell
1,632,827
-197,749
-11% -$92.7M 0.49% 37
2020
Q3 		$808M Sell
1,830,576
-130,774
-7% -$54M 0.54% 33
2020
Q2 		$711M Sell
1,961,350
-255,923
-12% -$85.8M 0.5% 39
2020
Q1 		$629M Buy
2,217,273
+519,525
+31% +$164M 0.54% 34
2019
Q4 		$552M Buy
1,697,748
+13,801
+0.8% +$4.18M 0.43% 42
2019
Q3 		$490M Buy
1,683,947
+10,168
+0.6% +$2.91M 0.43% 46
2019
Q2 		$492M Buy
1,673,779
+104,884
+7% +$28.9M 0.44% 43
2019
Q1 		$429M Buy
1,568,895
+60,869
+4% +$15.1M 0.4% 53
2018
Q4 		$335M Buy
1,508,026
+240,710
+19% +$56.5M 0.36% 61
2018
Q3 		$309M Buy
1,267,316
+24,941
+2% +$5.74M 0.33% 68
2018
Q2 		$257M Buy
1,242,375
+78,342
+7% +$16.6M 0.3% 72
2018
Q1 		$240M Buy
1,164,033
+34,168
+3% +$7.17M 0.31% 69
2017
Q4 		$215M Buy
1,129,865
+37,053
+3% +$7.1M 0.28% 77
2017
Q3 		$207M Sell
1,092,812
-21,485
-2% -$3.89M 0.29% 75
2017
Q2 		$194M Buy
1,114,297
+5,725
+0.5% +$962K 0.29% 76
2017
Q1 		$170M Sell
1,108,572
-5,906
-0.5% -$903K 0.26% 87
2016
Q4 		$157M Sell
1,114,478
-19,706
-2% -$2.91M 0.26% 87
2016
Q3 		$180M Buy
1,134,184
+22,203
+2% +$3.42M 0.3% 73
2016
Q2 		$164M Buy
1,111,981
+5,533
+0.5% +$817K 0.28% 77
2016
Q1 		$157M Buy
1,106,448
+4,875
+0.4% +$653K 0.27% 78
2015
Q4 		$157M Buy
1,101,573
+18,883
+2% +$2.52M 0.28% 77
2015
Q3 		$132M Sell
1,082,690
-66,735
-6% -$8.69M 0.26% 89
2015
Q2 		$149M Sell
1,149,425
-21,955
-2% -$2.86M 0.27% 85
2015
Q1 		$157M Buy
1,171,380
+84,771
+8% +$10.9M 0.28% 80
2014
Q4 		$138M Sell
1,086,609
-6,558
-0.6% -$797K 0.27% 86
2014
Q3 		$133M Buy
1,093,167
+18,651
+2% +$2.27M 0.27% 89
2014
Q2 		$127M Buy
1,074,516
+12,241
+1% +$1.44M 0.26% 92
2014
Q1 		$128M Buy
1,062,275
+156,281
+17% +$18.6M 0.27% 87
2013
Q4 		$100M Sell
905,994
-41,773
-4% -$4.15M 0.21% 114
2013
Q3 		$87.3M Sell
947,767
-165,711
-15% -$15M 0.19% 130
2013
Q2 		$94.2M Buy
+1,113,478
New +$92.7M 0.21% 110

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group's TMO Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group reduced its Thermo Fisher Scientific (TMO) stake by 1.5% in Q1 2026, selling an estimated $8.79M and leaving 1,078,539 shares worth $530M. The position accounts for 0.34% of the portfolio, ranked #53.

Sumitomo Mitsui Trust Group first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $900M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 1,078,539 shares of Thermo Fisher Scientific worth $530M as of Q1 2026.
  • Sumitomo Mitsui Trust Group sold 16,194 Thermo Fisher Scientific shares in Q1 2026, an estimated $8.79M.
  • Thermo Fisher Scientific made up 0.34% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #53 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Sumitomo Mitsui Trust Group's Thermo Fisher Scientific position peaked at $900M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.